Increased genomic burden of germline copy number variants is associated with early onset breast cancer: Australian breast cancer family registry
Open Access
- 16 March 2017
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research
- Vol. 19 (1) , 30
Abstract
Women with breast cancer who have multiple affected relatives are more likely to have inherited genetic risk factors for the disease. All the currently known genetic risk factors for breast cancer account for less than half of the average familial risk. Furthermore, the genetic factor(s) underlying an increased cancer risk for many women from multiple-case families remain unknown. Rare genomic duplications and deletions, known as copy number variants (CNVs), cover more than 10% of a human genome, are often not assessed in studies of genetic predisposition, and could account for some of the so-called “missing heritability”. We carried out a hypothesis-generating case-control study of breast cancer diagnosed before age 40 years (200 cases, 293 controls) using population-based cases from the Australian Breast Cancer Family Study. Genome-wide scanning for CNVs was performed using the Human610-Quad BeadChip and fine-mapping was conducted using PennCNV. We identified deletions overlapping two known cancer susceptibility genes, (BRCA1 and BLM), and a duplication overlapping SMARCB1, associated with risk. The number of deletions across the genome was 1.5-fold higher for cases than controls (P = 10-16), and 2-fold higher when only rare deletions overlapping genes (frequency <1%) were assessed (P = 5 × 10-4). Association tests of CNVs, followed by experimental validation of CNV calls, found deletions overlapping the OR4C11 and OR4P4 genes were associated with breast cancer (P = 0.02 and P = 0.03, respectively). These results suggest rare CNVs might have a role in breast cancer susceptibility, at least for disease at a young age.Keywords
Funding Information
- National Health and Medical Research Council
- Cancer Council NSW
- National Institutes of Health (UM1 CA164920)
- National Breast Cancer Foundation
This publication has 40 references indexed in Scilit:
- Copy Number Variation Analysis in Familial BRCA1/2-Negative Finnish Breast and Ovarian CancerPLOS ONE, 2013
- Rare Copy Number Variants Observed in Hereditary Breast Cancer Cases Disrupt Genes in Estrogen Signaling and TP53 Tumor Suppression NetworkPLOS Genetics, 2012
- Germline Copy Number Variations and Cancer PredispositionFuture Oncology, 2012
- Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciencesGenome Biology, 2010
- Germline copy number variation and cancer riskCurrent Opinion in Genetics & Development, 2010
- Common Genetic Variants Associated with Breast Cancer and Mammographic Density Measures That Predict DiseaseCancer Research, 2010
- Extensive Copy-Number Variation of the Human Olfactory Receptor Gene FamilyThe American Journal of Human Genetics, 2008
- Validation study of thelambdamodel for predicting theBRCA1orBRCA2mutation carrier status of North American Ashkenazi Jewish womenClinical Genetics, 2007
- Comparison of DNA- and RNA-Based Methods for Detection of TruncatingBRCA1 MutationsHuman Mutation, 2002
- BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancerBritish Journal of Cancer, 1998